引用本文: 丁锦希,黄泽华,钭江苑.澳大利亚专利药价格谈判制度实证研究与启示[J].中国卫生经济,2016,(12):116-119.[点击复制] .An empirical study of price negotiations among patent medicines in Australia[J].CHINESE HEALTH ECONOMICS,2016,(12):116-119.[点击复制]
【打印本页】 查看/发表评论 关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 980次   下载 60 本文二维码信息
码上扫一扫!
澳大利亚专利药价格谈判制度实证研究与启示
0
()
摘要:
本文旨在分析澳大利亚专利药物谈判定价制度,以诺华公司眼科药物诺适得在澳大利亚的药品价格谈判流程为研究对象,采用典型案例实证分析法,探讨其控价效应,以期为我国在有效控制药品价格、保证新医改政策有效推行的前提下完善专利药物价格谈判政策提供借鉴意义。
关键词:  
DOI:
基金项目:
An empirical study of price negotiations among patent medicines in Australia
()
Abstract:
This paper aims to analysis the Price Negotiation system of patent drugs in Australia. By using Novartis as the research case, we analysis and discuss the effect of price control in order to provide reference for our country under the health care reform and achieve remarkable success.
Key words:  

用微信扫一扫

用微信扫一扫